Clinical Trials Browser

Phase 2 × eravacycline × 90 days × Clear all

NCT05537896 2026-04-16

Prospective Evaluation of Xerava Prophylaxis in Hematological Malignancy Patients With Prolonged Neutropenia

Phase 2 Recruiting

Other hematologic neoplasm

Neutropenia, Hematologic Neoplasms